Please assess the completion status of the following clinical trial:

Trial Title: The (PIVOTAL) Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 40 to 90 years of age~* Meet all indications for use as stated in the Medtronic Vascular AAA Endograft Instructions for Use~* Maximum aneurysm diameter of 4-5cm~* If female patient with child bearing potential, must have a documented negative pregnancy test within seven(7)days prior to inclusion~* Patient is willing and able to comply with the specified follow-up evaluation~* Life expectancy at least 3 years~Exclusion Criteria:~* Meet any of the Contraindications stated in the Medtronic Vascular AAA Endograft instructions for Use~* Known co-existing condition with a life expectancy of less than 3 years~* Major surgical or interventional procedure (vascular and/or non-vascular)within 30 days prior to study enrollment~* Subjects enrolled in another clinical trial or anticipated to be included into a trial, which may interfere with this study, or subjects already enrolled in this trial before.~* Planned conduit procedure for introduction of endograft

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Surveillance (Type: NO_INTERVENTION): None
- Early Endovascular Repair (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).